Can-Fite Biopharma Ltd. Announces $8.0 M At-The-Market Registered Direct Offering
Sichenzia Ross Friedman Ference LLP Advises Can-Fite Biopharma Ltd. On A $8.0 M At-The-Market Registered Direct Offering
New York, NY – (Global Newswire) – 12/20/2014 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Israeli biopharmaceutical company, Can-Fite Biopharma Ltd. (TASE: CFBI; NYSE MKT: CANF) on an at-the-market registered direct offering of for gross proceeds of $8,000,000. The Sichenzia Ross Friedman Ference LLP team was led by Partner Gregory Sichenzia, Associates Gary Emmanuel and Avital Even-Shoshan. H.C. Wainwright & Co., LLC acted as the Placement Agent in the offering.
- Sichenzia Ross Ference LLP代表Bullfrog Gold收购Barrick Gold的资产并进行2200万加元的私募 - November 5, 2020
- Sichenzia Ross Ference LLP代表Jupiter Wellness，Inc.进行首次公开发行和在纳斯达克上市 - November 4, 2020
- 八位Sichenzia Ross Ference LLP律师入选2020年超级律师名单 - November 3, 2020